Skip to main content

. 1980 May 31;280(6227):1300–1301. doi: 10.1136/bmj.280.6227.1300-a

Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.

G Reach, M Thibonnier, C Chevillard, P Corvol, P Milliez

PMCID: PMC1601614 PMID: 7388518

1300

Images in this article

p1300-a
on p.1300

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Briggs R. S., Birtwell A. J., Pohl J. E. Hypertensive response to labetalol in phaeochromocytoma. Lancet. 1978 May 13;1(8072):1045–1046. doi: 10.1016/s0140-6736(78)90772-9. [DOI] [PubMed] [Google Scholar]
Brittain R. T., Levy G. P. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681–684. [PubMed] [Google Scholar]
Da Prada M., Zürcher Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci. 1976 Oct 15;19(8):1161–1174. doi: 10.1016/0024-3205(76)90251-4. [DOI] [PubMed] [Google Scholar]
Rosei E. A., Brown J. J., Lever A. F., Robertson A. S., Robertson J. I., Trust P. M. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):809–815. [PubMed] [Google Scholar]

ACTIONS

RESOURCES